ASBP
Aspire Biopharma Holdings, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
Kraig T. Higginson
IPO Date
2025-02-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Aspire Biopharma Holdings, Inc.
CEO
Kraig T. Higginson
IPO Date
2025-02-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US